# The Effect of Branched-chain Amino Acid (BCAA) on the Progression of Primary Liver Cancer

> **NCT02327819** · NA · UNKNOWN · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 60 (estimated)

## Conditions studied

- Primary Liver Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** Branched-chain amoni acids (BCAA)
- **DIETARY_SUPPLEMENT:** non-BCAA protein supplement

## Key facts

- **NCT ID:** NCT02327819
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2015-12
- **Final completion:** —
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2014-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02327819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02327819, "The Effect of Branched-chain Amino Acid (BCAA) on the Progression of Primary Liver Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02327819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*